
Rasha Aboelhassan/LinkedIn
May 17, 2025, 15:36
Rasha Aboelhassan: Should we Give Chemotherapy with Immunotherapy as a Neoadjuvant Setting in stage I TNBC?
Rasha Aboelhassan, Senior Oncology Consultant at Nasser Institute Hospital, shared a post on LinkedIn:
“Elisabetta Munzone
Very smart, talented and professional presentation to solve debate in stage I TNBC :
Should we give chemotherapy with immunotherapy as neoadjuvant setting?”
More posts featuring Rasha Aboelhassan
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 17, 2025, 17:21
May 17, 2025, 16:12
May 17, 2025, 16:10
May 17, 2025, 15:37
May 17, 2025, 15:28
May 17, 2025, 15:15